These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 8783390)
21. Neuroleptics cause stimulation of dopamine D1 receptors and their desensitization after chronic treatment. Imperato A; Obinu MC; Carta G; Mascia MS; Casu MA; Dazzi L; Gessa GL Eur J Pharmacol; 1994 Oct; 264(1):55-60. PubMed ID: 7828643 [TBL] [Abstract][Full Text] [Related]
22. Serotonergic regulation of acetylcholine release in rat frontal cortex. Hirano H; Day J; Fibiger HC J Neurochem; 1995 Sep; 65(3):1139-45. PubMed ID: 7643092 [TBL] [Abstract][Full Text] [Related]
23. Environmental enrichment reduces the function of D1 dopamine receptors in the prefrontal cortex of the rat. Del Arco A; Segovia G; Canales JJ; Garrido P; de Blas M; García-Verdugo JM; Mora F J Neural Transm (Vienna); 2007 Jan; 114(1):43-8. PubMed ID: 16955373 [TBL] [Abstract][Full Text] [Related]
24. N-desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors. Li Z; Huang M; Ichikawa J; Dai J; Meltzer HY Neuropsychopharmacology; 2005 Nov; 30(11):1986-95. PubMed ID: 15900318 [TBL] [Abstract][Full Text] [Related]
25. D1 dopamine receptor agonist-induced Fos-like immunoreactivity occurs in basal forebrain and mesopontine tegmentum cholinergic neurons and striatal neurons immunoreactive for neuropeptide Y. Robertson GS; Staines WA Neuroscience; 1994 Mar; 59(2):375-87. PubMed ID: 7911982 [TBL] [Abstract][Full Text] [Related]
26. AC260584 (4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one), a selective muscarinic M1 receptor agonist, increases acetylcholine and dopamine release in rat medial prefrontal cortex and hippocampus. Li Z; Bonhaus DW; Huang M; Prus AJ; Dai J; Meltzer HY Eur J Pharmacol; 2007 Oct; 572(2-3):129-37. PubMed ID: 17628522 [TBL] [Abstract][Full Text] [Related]
27. Increases in hippocampal and frontal cortical acetylcholine release associated with presentation of sensory stimuli. Inglis FM; Fibiger HC Neuroscience; 1995 May; 66(1):81-6. PubMed ID: 7637877 [TBL] [Abstract][Full Text] [Related]
28. Different sensitivity of in vivo acetylcholine transmission to D1 receptor stimulation in shell and core of nucleus accumbens. Consolo S; Caltavuturo C; Colli E; Recchia M; Di Chiara G Neuroscience; 1999; 89(4):1209-17. PubMed ID: 10362308 [TBL] [Abstract][Full Text] [Related]
29. Lesions of the mesotelencephalic dopamine system enhance the effects of selective dopamine D1 and D2 receptor agonists on striatal acetylcholine release. Robertson GS; Hubert GW; Tham CS; Fibiger HC Eur J Pharmacol; 1992 Aug; 219(2):323-5. PubMed ID: 1358643 [TBL] [Abstract][Full Text] [Related]
30. The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors. Andringa G; Drukarch B; Leysen JE; Cools AR; Stoof JC Eur J Pharmacol; 1999 Jan; 364(1):33-41. PubMed ID: 9920182 [TBL] [Abstract][Full Text] [Related]
31. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices. Ramírez MJ; Cenarruzabeitia E; Lasheras B; Del Rio J Brain Res; 1997 May; 757(1):17-23. PubMed ID: 9200494 [TBL] [Abstract][Full Text] [Related]
32. Amphetamine-stimulated cortical acetylcholine release: role of the basal forebrain. Arnold HM; Fadel J; Sarter M; Bruno JP Brain Res; 2001 Mar; 894(1):74-87. PubMed ID: 11245817 [TBL] [Abstract][Full Text] [Related]
33. Increases in striatal acetylcholine by SKF-38393 are mediated through D1 dopamine receptors in striatum and not the frontal cortex. Zocchi A; Pert A Brain Res; 1993 Nov; 627(2):186-92. PubMed ID: 8298961 [TBL] [Abstract][Full Text] [Related]
34. Dopaminergic regulation of serotonin release in the substantia nigra of the freely moving rat using microdialysis. Thorré K; Sarre S; Smolders I; Ebinger G; Michotte Y Brain Res; 1998 Jun; 796(1-2):107-16. PubMed ID: 9689460 [TBL] [Abstract][Full Text] [Related]
35. Dopamine D1 receptor stimulation increases striatal acetylcholine release in the rat. Damsma G; Tham CS; Robertson GS; Fibiger HC Eur J Pharmacol; 1990 Sep; 186(2-3):335-8. PubMed ID: 1981190 [TBL] [Abstract][Full Text] [Related]
36. Alterations in dopaminergic modulation of prefrontal cortical acetylcholine release in post-pubertal rats with neonatal ventral hippocampal lesions. Laplante F; Srivastava LK; Quirion R J Neurochem; 2004 Apr; 89(2):314-23. PubMed ID: 15056275 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of synaptically evoked cortical acetylcholine release by adenosine: an in vivo microdialysis study in the rat. Materi LM; Rasmusson DD; Semba K Neuroscience; 2000; 97(2):219-26. PubMed ID: 10799754 [TBL] [Abstract][Full Text] [Related]
38. Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors. Imperato A; Obinu MC; Casu MA; Mascia MS; Dazzi L; Gessa GL J Pharmacol Exp Ther; 1993 Aug; 266(2):557-62. PubMed ID: 8102643 [TBL] [Abstract][Full Text] [Related]
39. Adenosine A1 receptors control dopamine D1-dependent [(3)H]GABA release in slices of substantia nigra pars reticulata and motor behavior in the rat. Florán B; Barajas C; Florán L; Erlij D; Aceves J Neuroscience; 2002; 115(3):743-51. PubMed ID: 12435413 [TBL] [Abstract][Full Text] [Related]
40. A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets. Kebabian JW; Britton DR; DeNinno MP; Perner R; Smith L; Jenner P; Schoenleber R; Williams M Eur J Pharmacol; 1992 Dec; 229(2-3):203-9. PubMed ID: 1362704 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]